The matrix metalloproteinases and their natural inhibitors: prospects for treating degenerative tissue diseases
- 31 December 1992
- journal article
- review article
- Published by Elsevier in Trends in Biotechnology
- Vol. 10 (6) , 200-207
- https://doi.org/10.1016/0167-7799(92)90214-g
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- The origin of matrix metalloproteinases and their familial relationshipsFEBS Letters, 1991
- Matrix metalloproteinase degradation of elastin, type IV collagen and proteoglycan. A quantitative comparison of the activities of 95 kDa and 72 kDa gelatinases, stromelysins-1 and -2 and punctuated metalloproteinase (PUMP)Biochemical Journal, 1991
- Proteolytic inactivation of human α1 antitrypsin by human stromelysinFEBS Letters, 1991
- Cancer metastasis and angiogenesis: An imbalance of positive and negative regulationCell, 1991
- A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomasNature, 1990
- Characterization of 58-kilodalton human neutrophil collagenase: comparison with human fibroblast collagenaseBiochemistry, 1990
- Mechanisms of activation of tissue procollagenase by matrix metalloproteinase 3 (stromelysin)Biochemistry, 1990
- Stepwise activation mechanisms of the precursor of matrix metalloproteinase 3 (stromelysin) by proteinases and (4-aminophenyl)mercuric acetateBiochemistry, 1990
- Rheumatoid ArthritisNew England Journal of Medicine, 1990
- Inactivation of human plasma α1‐proteinase inhibitor by human PMN leucocyte collagenaseFEBS Letters, 1990